Hap Trading, LLC Cyclerion Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.47 - $1.29 $5,076 - $13,932	-10,800 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.96 - $1.78 $15,360 - $28,480	-16,000 Reduced 59.7%	10,800 $1,000
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.99 $18,252 - $34,983	11,700 Added 77.48%	26,800 $8,000
Q3 2021 Nov 10, 2021	BUY	$2.73 - $4.13 $41,223 - $62,363	15,100 New	15,100 $7,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $185M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.